| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $567.6M | +17.6% |
| Cost of Revenue | $334.1M | +18.5% |
| Gross Profit | $233.5M | +16.3% |
| R&D Expense | $8.4M | +20.5% |
| SG&A Expense | $158.3M | +12.7% |
| Operating Income | $66.8M | +18.1% |
| Pre-tax Income | $54.2M | +2.4% |
| Income Tax | $18.1M | +26.6% |
| Net Income | $36.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $93.5M | +60.3% |
| Inventory | $82.4M | +1.7% |
| Current Assets | $327.6M | +33.2% |
| Total Assets | $652.7M | +51.4% |
| Current Liabilities | $94.1M | -1.1% |
| Long-term Debt | $211.8M | +65.7% |
| Total Liabilities | $341.2M | +45.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $31.8M | -56.6% |
| Capital Expenditures | $5.7M | -15.7% |
| Investing Cash Flow | -$147.4M | -2161.1% |
| Financing Cash Flow | $152.7M | +717.5% |
| Free Cash Flow | $26.1M | -60.7% |
| -6.5% |
| EPS (Basic) | $0.90 | -12.6% |
| EPS (Diluted) | $0.90 | -11.8% |
| Stockholders' Equity |
| $311.5M |
| +58.0% |